Short interest for SecureWorks gives investors a sense of the degree to which investors are betting on the decline of SecureWorks's stock. Short interest data is updated every two weeks.

SecureWorks Stock (NASDAQ:SCWX), Short Interest Report

SecureWorks

SecureWorks Corp is a cybersecurity provider of technology-driven solutions singularly focused on protecting its customers by outpacing and outmaneuvering the adversary. The company offers its customers the following services; software-as-a-service, or SaaS, solutions, managed solutions, and professional services, including incident response and adversarial services. Its solutions enable organizations to fortify their cyber defenses to prevent security breaches, detect malicious activity in real-time, prioritize and respond to security incidents, and predict emerging threats. The company's products consist of MDR, XDR, Threat Hunting, Log Management, NGAV, EDR, IDPS.

Long Ideas

News

Small Cap

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

CDMO

KALV

SCWX

STAA

Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.

Insiders Buying KalVista Pharmaceuticals And 3 Other Stocks

Movers

SentinelOne, Inc. (NYSE: S) shares are trading higher Tuesday on continued upward momentum.

What&#39;s Going On With SentinelOne Stock?

Penny Stocks

BDTX

DOMO

Although US stocks closed lower on Friday, there were a few notable insider trades.

$4.7M Bet On Black Diamond Therapeutics? Check Out These 3 Stocks Insiders Are Buying

SecureWorks Corp

TRAK

ReposiTrak Leveraging Its Established Inventory Management And Out-of-stock Reduction Saas Platform, Is Preparing To Welcome 20 New Seafood Companies Into The Repositrak Traceability Network

WIIM

INVZ

Innoviz Technologies shares are trading higher after the company reported better-than-expected Q1 revenue and issued Q2 revenue guidance.

Needham analyst Ryan Koontz reiterates RingCentral (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNG#NYSE">RNG</a>) with a Buy and maintains $42 price target.

Price Target

Reiteration

Analyst Ratings

Needham Reiterates Buy on RingCentral, Maintains $42 Price Target

Reynolds Consumer Prods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REYN#NASDAQ">REYN</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.22 by 4.55 percent. This is a 187.5 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $833.000 million which beat the analyst consensus estimate of $814.970 million by 2.21 percent. This is a 4.69 percent decrease over sales of $874.000 million the same period last year.

Earnings

Earnings Beats

REYN

Reynolds Consumer Prods Q1 2024 Adj EPS $0.23 Beats $0.22 Estimate, Sales $833.000M Beat $814.970M Estimate

Cash, cash equivalents and marketable securities were $88.8 million as of March 31, 2024.

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

Avadel Pharmaceuticals Q1 Cash and Equivalents $88.8M

EXFY

Expensify Announced The Upcoming Launch Of Their New Travel Platform: Expensify Travel

Guidance

Broadridge Expects FY24 Recurring Revenue Growth Constant Currency At Low End Of 6% - 9% Guidance Range, Adjusted EPS Growth At The Middle Of 8% - 12% Range

SHOP

Shopify Says Gross Margin For Q2 Is Expected To Decrease By Approximately 50 Basis Points Compared To Q1 2024

Baird analyst David Manthey maintains Hillman Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLMN#NASDAQ">HLMN</a>) with a Outperform and raises the price target from $10 to $11.

HLMN

Baird Maintains Outperform on Hillman Solns, Raises Price Target to $11

Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.21) by 42.86 percent. This is a 37.5 percent increase over losses of $(0.48) per share from the same period last year.

Earnings Misses

Avadel Pharmaceuticals Q1 2024 GAAP EPS $(0.30) Misses $(0.21) Estimate, Revenue $0

2seventy bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSVT#NASDAQ">TSVT</a>) reported quarterly losses of $(0.81) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(1.08) per share from the same period last year. The company reported quarterly sales of $12.44 million which missed the analyst consensus estimate of $14.08 million by 11.68 percent. This is a 70.12 percent decrease over sales of $41.62 million the same period last year.

TSVT

2seventy bio Q1 Adj $(0.81), Inline, Sales $12.44M Miss $14.08M Estimate

R1 RCM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCM#NASDAQ">RCM</a>) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.01) by 700 percent. The company reported quarterly sales of $603.90 million which missed the analyst consensus estimate of $609.77 million by 0.96 percent. This is a 10.69 percent increase over sales of $545.60 million the same period last year.

R1 RCM Q1 EPS $(0.08) Misses $(0.01) Estimate, Sales $603.90M Miss $609.77M Estimate

Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.66) by 3.03 percent. This is a 1.49 percent decrease over losses of $(0.67) per share from the same period last year. The company reported quarterly sales of $7.679 million which missed the analyst consensus estimate of $9.125 million by 15.85 percent. This is a 26.02 percent decrease over sales of $10.380 million the same period last year.

MRNS

Marinus Pharma Q1 2024 GAAP EPS $(0.68) Misses $(0.66) Estimate, Sales $7.679M Miss $9.125M Estimate

Caesarstone (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTE#NASDAQ">CSTE</a>) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.16) by 18.75 percent. This is a 23.53 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $118.292 million which missed the analyst consensus estimate of $126.703 million by 6.64 percent. This is a 21.47 percent decrease over sales of $150.633 million the same period last year.

CSTE

Caesarstone Q1 2024 Adj EPS $(0.13) Beats $(0.16) Estimate, Sales $118.292M Miss $126.703M Estimate

NYT Sees Q2 Total Subscription Revenue Up 6-8%

TripAdvisor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.02 by 500 percent. The company reported quarterly sales of $395.00 million which beat the analyst consensus estimate of $394.86 million by 0.03 percent. This is a 6.47 percent increase over sales of $371.00 million the same period last year.

TRIP

TripAdvisor Q1 2024 Adj EPS $0.12 Beats $0.02 Estimate, Sales $395.00M Beat $394.86M Estimate

Information regarding the Company&#39;s&nbsp;outlook&nbsp;for fiscal 2024 is provided in the table below:
<table border="0" cellpadding="1" cellspacing="0">
<tbody>
<tr>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="3" rowspan="1">
Updated&nbsp;Outlook
</td>
<td colspan="3" rowspan="1">
Prior&nbsp;Outlook
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
System-wide SSS growth
</td>
<td colspan="1" rowspan="1">
6
</td>
<td colspan="1" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
8&nbsp;%
</td>
<td colspan="1" rowspan="1">
6
</td>
<td colspan="1" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
9&nbsp;%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
System-wide store additions
</td>
<td colspan="1" rowspan="1">
no
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
change
</td>
<td colspan="1" rowspan="1">
140
</td>
<td colspan="1" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
170
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Net revenues
</td>
<td colspan="1" rowspan="1">
$1.6
</td>
<td colspan="1" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
$1.65 billion
</td>
<td colspan="1" rowspan="1">
$1.6
</td>
<td colspan="1" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
$1.7 billion
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted EBITDA
</td>
<td colspan="1" rowspan="1">
$430
</td>
<td colspan="1" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
$455 million
</td>
<td colspan="1" rowspan="1">
$420
</td>
<td colspan="1" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
$460 million
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Capital expenditures
</td>
<td colspan="1" rowspan="1">
no
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
change
</td>
<td colspan="1" rowspan="1">
$185
</td>
<td colspan="1" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
$215 million
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted EPS
</td>
<td colspan="1" rowspan="1">
$1.45
</td>
<td colspan="1" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
$1.65
</td>
<td colspan="1" rowspan="1">
$1.40
</td>
<td colspan="1" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
$1.65
</td>
</tr>
</tbody>
</table>

Valvoline Expects FY24 Revenue of $1.60B-$1.65B (Prior $1.60B-$1.70B) Vs $1.635B Est, Adj EPS of $1.45-$1.65 (Prior $1.40-$1.65) Vs $1.60 Est

Oshkosh Disclosed That It Has Entered Into A Definitive Agreement To Acquire AUSACORP S.L. For An Undisclosed Amount

Vertex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERX#NASDAQ">VERX</a>) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.13 by 15.38 percent. The company reported quarterly sales of $156.781 million which beat the analyst consensus estimate of $154.914 million by 1.20 percent. This is a 18.10 percent increase over sales of $132.751 million the same period last year.

VERX

Vertex Q1 2024 Adj EPS $0.15 Beats $0.13 Estimate, Sales $156.781M Beat $154.914M Estimate

Biotech

Health Care

General

MCRB

Seres Therapeutics' Q1 Cash And Cash Equivalents Of $111.2M Is Expected To Provide Cash Runway Into Q4 Of 2024

Notable earnings before Thursday's open

SecureWorks Q4 2024 Earnings Preview

SecureWorks Non-GAAP EPS of $0.08 beats by $0.12, revenue of $89.2M beats by $2.08M

SecureWorks Corp. 2024 Q4 - Results - Earnings Call Presentation

SecureWorks Corp. (SCWX) Q4 2024 Earnings Call Transcript

In a report released today, Mike Cikos from Needham maintained a Hold rating on SecureWorks (SCWX – Research Report). The company's shares opened t...

Needham Sticks to Its Hold Rating for SecureWorks (SCWX)

Barclays analyst Saket Kalia maintained a Sell rating on SecureWorks (SCWX – Research Report) yesterday and set a price target of $6.00. The compan...

SecureWorks (SCWX) Gets a Sell from Barclays

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Canadian Solar (CSIQ – Research Report), SecureWor...

Analysts' Opinions Are Mixed on These Technology Stocks: Canadian Solar (CSIQ), SecureWorks (SCWX) and Synopsys (SNPS)

SecureWorks Corp (SCWX) has shared an update. SecureWorks Corp. has announced the appointment of William (Bill) H. Cary as a Class III director to ...

SecureWorks Appoints New Director and Audit Committee Chair

SecureWorks Corp. (SCWX) has disclosed a new risk, in the Corporate Activity and Growth category. SecureWorks Corp. faces a significant business ri...

SecureWorks Corp.'s Revenue at Risk: The Critical Need for Effective Taegis Subscription Strategy Implementation

AGEN

AUTL

BEKE

CION

CNTY

CSIQ

FUTU

GIII

GOCO

HNHAF

INFU

KPLT

MOMO

RNMBF

RWEOY

SNPS

URGN

XNET

Press Releases

Secureworks® Announces Third Quarter Fiscal 2024 Results

Secureworks and SentinelOne® Deliver Trailblazing Global Joint Go-To-Market Program to Decrease Cyber Risk

Secureworks Threat Score Ushers In A New Age Of Cybersecurity AI

Secureworks to Report Fourth Quarter and Full Year Fiscal 2024 Financial Results on March 14, 2024

Happiest Minds partners with Secureworks to deliver next-gen XDR Services

Secureworks Earns Frost & Sullivan Competitive Strategy Leadership Award in the Global Extended Detection and Response Market

Secureworks Announces Fourth Quarter and Full Year Fiscal 2024 Results

Secureworks Appoints William Cary to its Board of Directors

Secureworks Leads with Advanced Integration of Threat Detection and Vulnerability Risk for Expedited Threat Resolution

-

-

-

-

-

-

-

-

-

-

-

-

-

-

SecureWorks Stock (NASDAQ:SCWX), Short Interest Report

People Also Watch